EXPLORING THE POSSIBILITIES OF AUTOMATED MONITORING OF MEDICAL AND PHARMACEUTICAL SCIENTIFIC LITERATURE FOR PHARMACOVIGILANCE PURPOSES
DOI:
https://doi.org/10.11603/2312-0967.2025.1.15206Keywords:
pharmacovigilance, literature monitoring, medical and pharmaceutical periodicals, automation, digital technologiesAbstract
The aim of the work . To assess the potential and effectiveness of automated monitoring of medical and pharmaceutical literature for pharmacovigilance purposes. The research evaluates the impact of automation on analysis duration, accuracy of identifying relevant information, and reduction of workload for specialists, based on data collected from Ukrainian periodicals published in 2024.
Materials and Methods. The analysis included 113 Ukrainian medical and pharmaceutical open-access periodicals actively published during 2024. Optical Character Recognition (OCR) and text analysis methods were applied to automatically detect mentions of medicinal products. Time expenditure for data processing was compared between manual and automated approaches.
Results and Discussion. A total of 482 journal issues were analyzed. The automated approach reduced the average time required to process a single article from 11 to 1.5 minutes, resulting in a sevenfold decrease in time expenditure. The study also examined the frequency of journal issue publication and compared periodicals with the highest and lowest publication rates in 2024. At the same time, the importance of retaining the role of a specialist for result validation and decision-making was emphasized. Key advantages of automation were identified, including improved responsiveness, reduced risk of human error, and continuous monitoring capabilities.
Conclusions. The study demonstrated that automation of medical and pharmaceutical literature monitoring can significantly reduce time costs (by a factor of seven) and lower the risk of human error. Future research may focus on optimizing detection algorithms, improving the handling of diverse data formats, and integrating automated systems into the broader information infrastructure of pharmaceutical companies.
References
European Medicines Agency. Guideline on good pharmacovigilance practices (GVP) - Module VI (Rev 2). EMA/873138/2011 Rev 2. 2017 Jul 28. Available from: https://surl.li/gwypzn
Wadhwa D, Kumar K, Batra S, Sharma S. Automation in signal management in pharmacovigilance – an insight. Brief Bioinform. 2021;22(4):bbaa363. DOI:10.1093/bib/bbaa363 DOI: https://doi.org/10.1093/bib/bbaa363
Mitchell A. Future of pharmacovigilance: the six stages of automation. Eur Pharm Rev. 2022. Available from: https://surl.li/rzyzqe
Horilyk A, Horilyk D, Demchun M. Challenges of local medical literature monitoring and possible automation. Drug Saf. 2022;45(10):1132–3.
Pathak A. Literature monitoring in pharmacovigilance: enhancing processes with artificial intelligence. 2024 Oct 10. Available from: https://surli.cc/nenann
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pharmaceutical Review / Farmacevtičnij časopis

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
.
- Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).